Arcturus Therapeutics Insider Trades
NASDAQ: ARCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Arcturus Therapeutics insider activity
No Arcturus Therapeutics insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows SASSINE ANDY (Chief Financial Officer) buying 1,238 shares at $16.56 on Aug 15, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ARCT's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ARCT insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 15, 2025 | SASSINE ANDYChief Financial Officer | Buy | 1,238 | $20.50K | Form 4 |
| Aug 15, 2025 | SASSINE ANDYChief Financial Officer | Buy | 1,238 | $20.50K | Form 4 |
| Oct 15, 2024 | Chivukula PadChief Scientific Officer & COO | Sale | 12,000 | $249.12K | Form 4 |
| Jun 14, 2024 | FARRELL PETER CDirector | Option exercise | 3,131 | — | Form 4 |
| Jun 14, 2024 | Markels JohnDirector | Option exercise | 3,131 | — | Form 4 |
| Jun 14, 2024 | BARLOW JAMES FDirector | Option exercise | 3,131 | — | Form 4 |
| Jun 14, 2024 | Marquet MagdaDirector | Option exercise | 3,131 | — | Form 4 |
| Jun 14, 2024 | HOLMES EDWARD WDirector | Option exercise | 3,131 | — | Form 4 |
| Jun 14, 2024 | Marantz Jing L.Director | Option exercise | 3,131 | — | Form 4 |
| Jun 12, 2024 | SASSINE ANDYChief Financial Officer | Sale | 50,000 | $1.60M | Form 4 |
| Jun 5, 2024 | Chivukula PadChief Scientific Officer & COO | Sale | 114 | $5.13K | Form 4 |
| Jun 3, 2024 | Chivukula PadChief Scientific Officer & COO | Sale | 26,000 | $1.04M | Form 4 |
| Mar 25, 2024 | Chivukula PadChief Scientific Officer & COO | Sale | 17,435 | $610.57K | Form 4 |
| Mar 19, 2024 | Chivukula PadChief Scientific Officer & COO | Sale | 8,565 | $299.84K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4